Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer

BACKGROUND: DNA methylation is one of the most promising biomarkers in predicting the prognosis of colorectal cancer (CRC). We aimed to develop a DNA methylation biomarker that could evaluate the prognosis of CRC. METHODS: A promising DNA methylation biomarker was developed by hypermethylated genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuan, Cai, Du, Huang, Yaoyi, Xie, Yumo, Shen, Dingcheng, Yuan, Ze, Liu, Xiaoxia, Huang, Meijin, Luo, Yanxin, Yu, Huichuan, Wang, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077670/
https://www.ncbi.nlm.nih.gov/pubmed/37020199
http://dx.doi.org/10.1186/s12885-023-10765-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077670/
https://www.ncbi.nlm.nih.gov/pubmed/37020199
http://dx.doi.org/10.1186/s12885-023-10765-x

Ejemplares similares